The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis. - Wikidata - awgldk - TriplyDB

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

http://www.wikidata.org/entity/Q38681168

about

A20 enhances the radiosensitivity of hepatocellular carcinoma cells to 60Co-γ ionizing radiation.EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN.miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells.Inhibition of LCMR1 and ATG12 by demethylation-activated miR-570-3p is involved in the anti-metastasis effects of metformin on human osteosarcoma.Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor Role of miR-520b in non-small cell lung cancer Machine learning identifies interacting genetic variants contributing to breast cancer risk: A case study in Finnish cases and controls LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p Eyes absent homologue 2 predicts a favorable prognosis in colorectal cancer MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells

P2860

Q47107783-86415A85-CB27-453F-8677-B1CCE92DA4C3 Q49497954-C8D402E6-A535-4B21-9584-E492D111ED3A Q50130129-6060B1B9-CCEE-45AF-BAED-475F4B07757A Q54970340-C503AF41-8FA7-41FB-9C9B-A87EDD1E5EF0 Q55127822-2007EF69-C9FD-41A1-9409-06C198897515 Q55438944-418D1F53-406A-4947-8FAE-5AD9C969A721 Q57074551-9AA6603E-9218-49B4-81BB-7B431AF3D07F Q58552553-F9426455-F06E-4EF8-B76A-79D8E60698B2 Q58769239-BC8FE869-C0B7-45A8-B675-68C2C6C2955E Q58778589-D25CAF86-800E-4495-8FAE-ECBF9E8E02F9 Q58795641-1B53B552-163C-4FE0-88B7-0C7449054B3A Q59135086-BD0F5B37-2DAC-48B4-8742-79233DAA0CB6

P2860

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

http://www.wikidata.org/entity/Q38681168

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

@en

type

label

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

@en

prefLabel

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

@en

P1433

Q38681168-C45BFC96-03E3-4639-8572-34358B14F423

P1476

Q38681168-FA027557-CEE0-4842-9ACF-B8F2B87E0A50

P2093

Q38681168-14A53465-322B-47B0-9D3A-908BA42A91DC

Q38681168-24203068-E594-4B7D-81CF-E10315FFCDF7

Q38681168-256A36BE-D41C-4387-90E2-60789287EDFD

Q38681168-490FE527-A2B4-4FDC-A8D8-4AEE05ABE2ED

Q38681168-4AEB0DF1-705B-4C74-8548-7258FC439247

Q38681168-5159CE06-21B7-43E6-828C-8D7FE62B4F77

Q38681168-64B3113C-E374-45ED-BF37-D6611C728138

Q38681168-83CA6992-8FE9-4793-A4B2-7A04A66B5B3B

Q38681168-93CE9D39-96F8-4D73-9BEC-F9F18E0848EE

Q38681168-960A8133-AFC3-4E23-B004-FF56553F9A5D

P2860

Q38681168-146B295C-B187-445E-AC3A-8C36A870BFB1

Q38681168-16947BE1-5958-42F5-8979-73514201FCA0

Q38681168-1977BCD1-54CC-413B-B1B3-D19A72259E04

Q38681168-19EC9FBD-2C0C-47C1-980E-79DF69BACDBC

Q38681168-1FA3A463-DD16-4F3E-9299-92B091A4222D

Q38681168-266D7852-86A2-4DBD-BCE6-2B6F78CC7604

Q38681168-2830ED4E-0FE6-4EDE-BA10-2266C88CED85

Q38681168-2EFF6BBD-15B7-4B95-A3D3-F313D523C734

Q38681168-34021756-0025-4183-958D-6D044CA53BDB

Q38681168-3898ED41-FB8D-4FEB-B117-7658C18E7A19

P2888

Q38681168-E0DC8000-F4C8-4B1E-8C58-E4A1170F07FE

P304

Q38681168-EC288F41-8DB8-48D4-8FDB-5E9B5AD9777F

P31

Q38681168-4339A0AD-C086-4BEF-9429-69EC0F12FF5E

P356

Q38681168-8E5EE2D7-3BC5-4F3F-A4AF-68EE8923D8D4

P433

Q38681168-0276616C-C7A5-4E07-80E3-B3B5291C8F60

P478

Q38681168-44486B84-3671-4023-AF80-3F14F635D4CA

P577

Q38681168-967CF415-F23A-4E6B-9C9A-F83439E65100

P6179

Q38681168-ED1DD255-2470-4A0B-8C1F-C41FDA1A35A7

P698

Q38681168-DCE5B46F-8CC5-49ED-B442-7D13646AD352

P932

Q38681168-706A0800-4443-4806-AB74-03A3A9E6DCB8

P356

P1433

Cell Death and Disease

P1476

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

@en

P2093

Jing Fu

http://www.w3.org/2001/XMLSchema#string

Junjian Huang

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Qi Song

http://www.w3.org/2001/XMLSchema#string

Qinong Ye

http://www.w3.org/2001/XMLSchema#string

Quanbo Ji

http://www.w3.org/2001/XMLSchema#string

Shuai Jin

http://www.w3.org/2001/XMLSchema#string

Tao Wang

http://www.w3.org/2001/XMLSchema#string

Tian Hong

http://www.w3.org/2001/XMLSchema#string

Wei Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

The epithelial-mesenchymal transition generates cells with properties of stem cells

ErbB receptors: from oncogenes to targeted cancer therapies

Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications

MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4

Mechanisms of resistance to anti-EGFR therapy in colorectal cancer

Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase

MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

Breast cancer metastasis: markers and models

P2888

P304

e2928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2017.325

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090652677

http://www.w3.org/2001/XMLSchema#string

P698

28703807

http://www.w3.org/2001/XMLSchema#string

P932

5550870

http://www.w3.org/2001/XMLSchema#string